522 results on '"Santillan, Mark"'
Search Results
152. Vasopressin infusion throughout pregnancy causes placental pathology in mice consistent with preeclampsia
153. Arterial stiffness but not physical activity levels and vascular endothelial function are altered in early/mid pregnancy in women who develop preeclampsia
154. Evaluating the association of physical activity and weight gain in pregnancy
155. Impact of vasopressin receptors on regulation of immune response in preeclampsia
156. Elevated vasopressin in pregnant mice induces T-helper subset alterations consistent with human preeclampsia
157. 109: Plasma endothelin-1, arterial stiffness, and mean arterial pressure in the first trimester are predictive of the diagnosis of preeclampsia
158. Abstract 144: Reduced Placental Regulator of G-Protein Signaling-2 (RGS2) and Preeclampsia
159. Abstract P256: Vasopressin Infusion During Pregnancy in Mice Induces Early Histological Placental Phenotypes of Preeclampsia
160. Abstract 035: Fetal Growth Restriction is Associated with Spontaneous Gestational Hypertension in African Green Monkeys
161. Abstract P261: Vasopressin System Components are Dysregulated in Human Preeclamptic Placenta
162. Abstract P270: First Trimester Elevation in Circulating Endothelin-1 and Arterial Stiffness are Predictive of Late Pregnancy Preeclampsia
163. Abstract P262: Vasopressin Receptors Regulate Immune Responses in Preeclampsia
164. Vasopressin Antagonists Regulate Immune Responses in Preeclampsia
165. Arginine vasopressin acts directly upon human placental trophoblasts to elicit calcium responses
166. Vasopressin Induces Discrete Symptoms of Preeclampsia through Receptor‐ and Gestational Age‐Specific Mechanisms
167. Physiological Significance of Angiotensin AT1A Receptors in Vasopressin‐Producing Cells
168. Determining the role of Maternal Leptin and Activity in Pregnancy Outcomes
169. Building Bridges for Collaboration: the University of Iowa Women's Health Tissue Repository
170. Reduced Placental Regulator of G‐Protein Signaling‐2 (RGS2) and Preeclampsia
171. Elevated Chemokine C-C motif ligand 2 (CCL2) early in pregnancy is associated with increased risk of preeclampsia in obese parturients
172. 966: Pregnancy-associated suppression of plasma osmolality is exaggerated in preeclampsia: a window to novel early pathologic mechanisms
173. Abstract 033: Differential Vasopressin Receptor Expression on CD4+ T Cells from Mouse and Human Preeclamptic Pregnancies
174. Abstract P321: Differential Leptin Levels are Associated with Hypertensive Disorders of Pregnancy and Adverse Pregnancy Outcomes
175. Abstract P322: Vasopressin Release is Enhanced Before the Development of Preeclampsia in Humans Despite Exaggerated Suppression of Plasma Osmolality
176. Abstract P323: Arginine Vasopressin and Indoleamine 2,3 Dioxygenase: The Early Immunovascular Interface in Preeclampsia
177. Abstract P178: Vasopressin Induces Discrete Symptoms of Preeclampsia Through Receptor- and Gestational Age-specific Mechanisms
178. Abstract P177: Reduced Expression of Regulator of G-Protein Signaling-2 (RGS2) in the Placenta During Preeclampsia
179. Abstract 020: Physiological Significance of Angiotensin AT 1A Receptors in Vasopressin-producing Cells of the Supraoptic Nucleus
180. Breaking a Mother’s Heart
181. Acute and Chronic Biological Effects of Copeptin on Vascular Function in Mice and Humans
182. Introduction to the American Heart Association’s Hypertension Strategically Focused Research Network
183. Does leptin predict successful induction of labor?
184. The relationship between obesity, pregnancy, and levels of indoleamine 2,3-dioxygenase
185. 779: First trimester urine copeptin predicts the development of preeclampsia
186. Early Prediction of Preeclampsia: Hope for Early Intervention?
187. Mast Cells Release Chemokine CCL2 in Response to Parkinsonian Toxin 1-Methyl-4-Phenyl-Pyridinium (MPP+)
188. Vasopressin: the missing link for preeclampsia?
189. Angiotensin AT1A receptors expressed in vasopressin-producing cells of the supraoptic nucleus contribute to osmotic control of vasopressin.
190. Abstract P176: Predicting Preeclampsia Using Copeptin in Women at Low Risk of Disease
191. Abstract P094: Vasopressin Infusion in Mice During Pregnancy Results in Immune Alterations Consistent with Human Preeclampsia
192. Abstract P060: Angiotensin AT1A Receptors on Vasopressin-Expressing Cells are Dispensable for DOCA-salt Hypertension
193. Dopaminergic Toxin 1-Methyl-4-Phenylpyridinium, Proteins α-Synuclein and Glia Maturation Factor Activate Mast Cells and Release Inflammatory Mediators
194. Changes in antimüllerian hormone levels in early pregnancy are associated with preterm birth
195. Glia Maturation Factor Stimulates Release of Proinflammatory Mediators from Mast Cells
196. Vasopressin Infusion During Pregnancy is Associated with Cardiovascular and Metabolic Dysfunction in Offspring
197. Global fetal DNA methylation and birth outcomes in obese women
198. Adherence to the updated guidelines for the prevention of perinatal Group B streptococcal disease
199. [49-OR]
200. [33-OR]
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.